mutation and glucose metabolism in thyroid cancer patients : An 18 F-FDG-PET study
暂无分享,去创建一个
A. Ho | W. Weber | R. Tuttle | R. Grewal | J. Nagarajah
[1] Jason Li,et al. Response of BRAF-mutant melanoma to BRAF inhibition is mediated by a network of transcriptional regulators of glycolysis. , 2014, Cancer discovery.
[2] B. Cha,et al. Non-FDG-avid primary papillary thyroid carcinoma may not differ from FDG-avid papillary thyroid carcinoma. , 2013, Thyroid : official journal of the American Thyroid Association.
[3] Bo Hyun Kim,et al. Diagnostic value of metabolic tumor volume assessed by 18F-FDG PET/CT added to SUVmax for characterization of thyroid 18F-FDG incidentaloma , 2013, Nuclear medicine communications.
[4] P. Ladenson,et al. Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer. , 2013, JAMA.
[5] H. Ryu,et al. The value of preoperative PET–CT in papillary thyroid cancer , 2013, The Journal of international medical research.
[6] A. Piccardo,et al. Diagnostic and clinical significance of F-18-FDG-PET/CT thyroid incidentalomas. , 2012, The Journal of clinical endocrinology and metabolism.
[7] P. Ward,et al. Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. , 2012, Cancer cell.
[8] A. Bockisch,et al. Glucose Transporter 1 Expression, Tumor Proliferation, and Iodine/Glucose Uptake in Thyroid Cancer With Emphasis on Poorly Differentiated Thyroid Carcinoma , 2012, Clinical nuclear medicine.
[9] K. Schmid,et al. The BRAF V600E mutation in papillary thyroid carcinoma is associated with glucose transporter 1 overexpression. , 2011, Thyroid : official journal of the American Thyroid Association.
[10] R. Celestino,et al. Genetic Alterations in Poorly Differentiated and Undifferentiated Thyroid Carcinomas , 2011, Current genomics.
[11] M. Shah,et al. Role of BRAF in Thyroid Oncogenesis , 2011, Clinical Cancer Research.
[12] Chris Sander,et al. 18F-fluorodeoxy-glucose positron emission tomography marks MYC-overexpressing human basal-like breast cancers. , 2011, Cancer research.
[13] K. Kinzler,et al. Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells , 2009, Science.
[14] Mithat Gonen,et al. Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning. , 2006, The Journal of clinical endocrinology and metabolism.
[15] Y. Erdi,et al. Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] Z. Keidar,et al. PET/CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.